Expanding the Arsenal: Innovative Strategies to Treat Platinum Resistant Ovarian Cancer
Industry Supported Symposium

Target Audience

This symposium is designed for gynecologic oncologists, medical oncologists, researchers, clinical trial coordinators, and healthcare professionals involved in the treatment and management of ovarian cancer, as well as those interested in the latest advancements in cancer therapies.

Learning Objectives

Upon completion of the activities in this series, learners will demonstrate increased knowledge regarding:

1. Explore Recent Advancements in Ovarian Cancer:  Attendees will gain insights into the latest advancements in the treatment of advanced, platinum resistant high-grade epithelial ovarian cancer, focusing on innovative therapies beyond ADCs.
2. Discuss Competitive Landscape: Understand the current competitive landscape in ovarian cancer treatment, examining how emerging therapies can complement or enhance existing treatment paradigms.
3. Understand Treatment Efficacy: Treatment Outcomes: Evaluate the efficacy of new treatment options, highlighting their potential benefits for heavily pretreated patients facing significant challenges in managing ovarian cancer.
4. Engage in Collaborative Dialogue: Foster interactive dialogue among clinicians, and oncologists to discuss challenges, share experiences, and collaborate on future research directions in the treatment of ovarian cancer.